Friends of Mass General Canada Inc.
Charitable organizationResearch·3400 ONE FIRST CANADIAN PLACE · 100 KING STREET WEST · TORONTO, ON · M5X 1A4·BN 715537486RR0001
Last reported: F2024 filing · period ending 2024-12-31
What it does — in its own words
Ongoing programs
TO ADVANCE EDUCATION AND PROMTOE HEALTH BY CONDUCTING MEDICAL AND SCIENTIFIC RESEARCH AT MASSACHUSSETTS GENERAL HOSPITAL AND MAKING THE RESULTS PUBLICLY AVAILABLE AND BY ORGANIZING AND DELIVERING EDUCATIONAL PROGRAMS TO ALLOW STUDENTS PHYSICIANS AND OTHER HEALTHCARE PROFESSIONALS FROM AROUND THE WORLD TO SHARE KNOWLEDGE AND BEST PRACTICES IN MEDICINE
New programs
IN 2024 FMGC THROUGH ITS AGENCY AGREEMENT WITH MASSACHUSETTS GENERAL HOSPITAL LAUNCHED AND CONDUCTED SEVEREAL RESEARCH STUDIES: 1. ESTABLISHED THE SANDRA ARTHUR AND SARAH IRVING FUND FOR ANAL CANCER IMMUNOLOGY RESEARCH 2. STUDIED THE EFFECTS OF SMALL MOLECULES ON MULTISYSTEM SMOOTH MUSCLE DYSFUNCTION SYNDROME (MSMDS) USING PATIENT-DERIVED CELLS AND THE ACTA2 R179 MOUSE MODEL. 3. INVESTED IN THE JOHN AND ELIZABETH IRVING FUND FOR MOOD DISORDERS RESEARCH TO BE USED TO PROVIDE RESOURCES TO STUDY THE USE OF THE THYROID HORMONE T3 FOR AUGMENTATION OF ANTIDEPRESSANT MEDICATION IN INDIVIDUALS … Show more
IN 2024 FMGC THROUGH ITS AGENCY AGREEMENT WITH MASSACHUSETTS GENERAL HOSPITAL LAUNCHED AND CONDUCTED SEVEREAL RESEARCH STUDIES: 1. ESTABLISHED THE SANDRA ARTHUR AND SARAH IRVING FUND FOR ANAL CANCER IMMUNOLOGY RESEARCH 2. STUDIED THE EFFECTS OF SMALL MOLECULES ON MULTISYSTEM SMOOTH MUSCLE DYSFUNCTION SYNDROME (MSMDS) USING PATIENT-DERIVED CELLS AND THE ACTA2 R179 MOUSE MODEL. 3. INVESTED IN THE JOHN AND ELIZABETH IRVING FUND FOR MOOD DISORDERS RESEARCH TO BE USED TO PROVIDE RESOURCES TO STUDY THE USE OF THE THYROID HORMONE T3 FOR AUGMENTATION OF ANTIDEPRESSANT MEDICATION IN INDIVIDUALS WHO HAVE HAD EITHER A PARTIAL OR NO RESPONSE TO ANTIDEPRESSANT MEDICATIONS IN 2024 FMGC THROUGH ITS AGENCY AGREEMENT WITH MASSACHUSETTS GENERAL HOSPITAL ADVANCED EDUCATION BY ESTABLISHING THE JOHN AND ELIZABETH IRVING FELLOWSHIP IN ANTIDEPRESSANT RESEARCH TO PROVIDE RESOURCES FOR A TWO-YEAR FELLOWSHIP FOR EARLY-CAREER PSYCHIATRY-TRAINED AND LICENSED PHYSICIANS FROM THE US AND CANADA FOCUSING ON ANTIDEPRESSANT RESEARCH
Program descriptions from its F2024 T3010 filing, verbatim · self-reported · this is also the text our semantic search matches against. source ↗
Tier 1 — what we computed (open data)
From the charity's own F2024 T3010 filing. Self-reported; not independently verified. You can recompute every figure.
Cents to cause
T1 · computed (open data)96¢
Per its F2024 T3010, 96¢ of each dollar spent went to programs.
Sector median: 89¢ across 55,155 computed charities.
T3010 line 5000 ÷ 4950 · Self-reported on the T3010; not independently verified. source ↗
Operating overhead
T1 · computed (open data)4%
Management, administration, and fundraising as a share of total spending. We treat 5–35% as the typical range; we state the figure, you judge.
T3010 line (5010 + 5020) ÷ 4950 · Self-reported on the T3010; not independently verified. source ↗
Reserves
T1 · computed (open data)0 yr
Years current reserves could cover program spending.
Sector quartiles: 0.4 yr / 0.8 yr / 7.5 yr (p25 / median / p90).
T3010 line (4100 + 4140) ÷ 5000 · Self-reported on the T3010; not independently verified. source ↗
Total revenue
T1 · computed (open data)$1.9M
Last-reported total revenue.
T3010 line 4700 · Self-reported on the T3010; not independently verified. source ↗
Donor-funded
T1 · computed (open data)100%
Share of revenue from receipted donations.
T3010 line 4500 ÷ 4700 · Self-reported on the T3010; not independently verified. source ↗
Government-funded
T1 · computed (open data)0%
Share of revenue from federal, provincial, and municipal sources.
T3010 line 4570 (or 4540+4550+4560) ÷ 4700 · Self-reported on the T3010; not independently verified. source ↗
Over the years
Every figure as filed at each fiscal period end, 2022–2024.
| Period end | Revenue | Cents to cause | Overhead | Reserves |
|---|---|---|---|---|
| 2022-12-31 | — | — | — | — |
| 2023-12-31 | $3.8M | 87¢ | 13% | 0 yr |
| 2024-12-31 | $1.9M | 96¢ | 4% | 0 yr |
| trend |
From its T3010 filings (CRA annual releases) · self-reported, not audited by us · when a period is restated in a later release, the newest figures are shown · ✱ = cents-to-cause outside the valid 0–100% range (filing error; not used in rankings). source ↗
★ Tier 2 — Charity Intelligence (analyst-reviewed)
Not rated by Charity Intelligence. Their analysts cover 618 of Canada's 83,761 charities; absence of a rating says nothing about this charity. Our computed figures above stand on their own.
Board of directors
4 directors reported · 4 of 4at arm's length
- CAIRNCROSS, JOHN GREGORYDIRECTORarm's length
- SHEINER, ANDREWDIRECTORarm's length
- NICHOLSON, BRITAINDIRECTOR & PRESIDENTarm's length
- BECKLER NORTHROP, ERINDIRETOR & PRESIDENTarm's length
From its F2024T3010 filing (public CRA record), as filed. “Arm's length” means not related to other officials by family or business ties. source ↗
Right of reply
This charity hasn't added a response yet. When it does, it appears here, beside the numbers, and is never removed. Represent this charity? Submit a response.
Verify everything: full public record on CharityData.ca ↗ · CRA charities listing ↗